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Advanced age is associated with increased incidence of a variety of chronic disease states which share oxidative stress and
inflammation as causative role players. Furthermore, data point to a role for both cumulative oxidative stress and low grade
inflammation in the normal ageing process, independently of disease. Therefore, arguably the best route with which to address
premature ageing, as well as age-associated diseases such as diabetes, cardiovascular disease, and dementia, is preventativemedicine
aimed at modulation of these two responses, which are intricately interlinked. In this review, we provide a detailed account of
the literature on the communication of these systems in the context of ageing, but with inclusion of relevant data obtained in
other models. In doing so, we attempted to more clearly elucidate or identify the most probable cellular or molecular targets for
preventative intervention. In addition, given the absence of a clear pharmaceutical solution in this context, together with the ever-
increasing consumer bias for natural medicine, we provide an overview of the literature on grape (Vitis vinifera) derived products,
for which beneficial effects are consistently reported in the context of both oxidative stress and inflammation.
1. Introduction
With ageing, the capacity of the body to function optimally
declines. There is a combination of genetic and lifestyle
factors which may either accelerate or slow down the ageing
process. A number of chronic diseases are associated with
advanced age: these include cardiovascular disease (CVD),
diabetes, metabolic syndrome, and Alzheimer’s disease.This
results in an exponential increase in the disease burden on
modern society, relative to a few decades ago, due to longer
life expectancy. The World Health Organisation states that
from 2015 to 2050, the proportion of the world’s population
over 60 years will increase from 12% to 22% [1]. Taking
into consideration that predominant research in the field of
age-associated diseases considers the sixth decade of life to
be a risk factor for the rapid progression and onset of age-
associated diseases, the disease burden will almost double in
the next 35 years. It is thus vital not only to elucidate the
causes and progression of these chronic conditions, but also
to actively search and investigate potential preventative thera-
pies thatmay slow the processes contributing to physiological
ageing.
Although the ageing-associated chronic disease states
are each uniquely complex in terms of their aetiology,
development, and progression, they do share common aeti-
ologies which stem from two main entities, namely, cumu-
lative oxidative stress and chronic inflammation. Briefly,
oxidants are produced by normal cellmetabolism and various
physiological responses. However, when the production of
oxidants outweighs the capacity of endogenous antioxidant
systems, oxidative stress is incurred. Furthermore, while
inflammation is crucial for repair of tissue injury and primary
defence against invading pathogens and chemicals, it also
results in unintended detriment to previously uninjured
cells. Although these are necessary systems in the body,
both oxidative stress and the inflammatory response, if
unchecked, can have detrimental consequences which have
been linked to accelerated ageing and the progression of
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age-associated disease. We postulated that the effects of
the inflammatory immune system and oxidative stress on
allostatic load are interlinked. This has led us to investigate
the potential of antioxidants as treatment options to attenuate
the cumulative effects of both oxidative stress and chronic low
grade inflammation. Given the modern consumer bias for
natural medicines, we focused on a group of plant medicines
which are consistently associated with beneficial effects on
these processes in the literature, grape-derived polyphenols.
In this review, we will provide a more in-depth review of
interconnected molecular mechanisms of oxidative stress
and inflammation in the physiological ageing process, before
moving our focus to a discussion of the merits of these
plant medicines as potential preventative therapy in this
context.
2. Contribution of Oxidative Stress to
Premature Ageing
In the context of ageing, reactive oxygen and nitrogen species
(RONS) are generally the major molecules which contribute
significantly to oxidative stress. The most frequently stud-
ied free radicals are superoxide (O
2
−), hydrogen peroxide
(H
2
O
2
), hydroxyl radical (∙OH), peroxynitrite (ONO
2
−), and
nitric oxide (NO). The generation of these free radicals is
necessary as they are essential for host defence: phagocytic
cells use ROS to digest invading pathogens and debris.
Furthermore, they act as signalling molecules, regulating
cell growth and apoptosis, adhesion, and differentiation.
More specifically, RONS are formed during processes such
as the mitochondrial electron transport chain as well as
enzyme systems such as cytochrome P450, lipoxygenase
and cyclooxygenase, the NADPH-oxidase complex, xanthine
oxidase, and peroxisomes [2]. In contrast to these roles
in growth, repair, and immune functions which are all
beneficial to the host, these molecules also have the ability
to oxidise signalling molecules, DNA, macromolecules, and
cell structures such as lipid membranes of healthy host cells,
all of which are to the detriment of these cells. Usually, each
cell has defence mechanisms to counteract the occurrence
of oxidative stress. These endogenous enzymatic antioxidant
defences include superoxide dismutase (SOD), glutathione
peroxidase, catalases, glutathione/TrxR, and peroxiredoxins.
An appropriately nutritious diet is vital to maintain these
systems, as these natural antioxidants are supplemented or
replenished by antioxidant constituents of various fruits and
vegetables. It is only when the capacity of the body’s antiox-
idant defences is outweighed by the rate of production of
free radicals that oxidative stress is incurred by unquenched
free radicals which can alter surrounding cell structures and
environment.
With advancing age, various factors, among these is
a natural progressive decline in endogenous antioxidant
capacity, cause disruption in the balance between pro- and
antioxidant mechanisms and RONS accumulate beyond the
normal endogenous antioxidant system’s quenching capacity,
resulting in cumulative oxidative stress. Eventually this causes
cell damage which cannot be repaired by internal mecha-
nisms, leading to loss of organ mass and functionality, which
ultimately culminates in system dysfunction [3]. Indeed,
long-term oxidative stress states have been linked to various
diseases associated with advanced age, most notably diabetes,
chronic obstructive pulmonary disease (COPD), cardiovas-
cular disease, cancer, diabetes, and asthma [4]. Many of these
diseases are not only associated with ageing anymore, but
alsowith the high-obesity, high-stress, and sedentarymodern
lifestyle (albeit perhaps in milder form) [5]. It is thus vital
to address the prevention of these detrimental long-term
outcomes, as they are afflicting not only the aged, but also
relatively young populations, such as university students [6,
7].
The aetiological mechanism(s) of the various chronic
diseases mentioned are each different, as each disease has
its own complexities. However, chronic cumulative oxidative
stress is a common factor in these diseases, highlighting this
system as a vital therapeutic and/or preventative medicine
target [8].
Even in the absence of age-associated disease, various
theories have linked oxidative stress directly to the normal
ageing process. We briefly mention two here. Firstly, the Free
Radial Theory of Ageing proposes that the presence of free
radicals and their effects on cells are one of the causes of
cell ageing and subsequent cell death, which in turn lead
to loss of organ mass and other features of whole organism
ageing. This theory was first suggested by Harman in 1956
[9], who hypothesized that irradiation of cellular components
resulting from the liberation of ∙OH and ∙HO
2
radicals
would lead to dysfunction and mutations which cannot be
reversed and thus result in ageing. This theory was later
supported and expanded as research began elucidating the
details of his proposed theory, for example, by describing
the role of SOD [10]. Phenomenally, a very recent meta-
analysis [11] confirmed the sustained validity of this theory,
60 years later. Of course, given the technological advances
made over this period, it is no surprise that subsequent
research has added more detail on mechanisms in support
of this theory, although many unresolved questions remain
[12].
Secondly, the Replicative Senescence Theory is based on
the hypothesis that oxidative stress induces cell death and/or
senescence, which necessitates an increase in the rate of cell
replication. This in turn accelerates the detrimental effects
associated with repeated cycles of mitosis. Telomere length
and its accelerated shortening due to reparative replication
is the basis of this theory, which was first described by
Hayflick in 1965, in response to the observation of a decline
in functionality of cell cultures (fibroblasts) which had
undergone numerous cell divisions [13]. This phenomenon
was subsequently confirmed by experiments on primary
peripheral blood mononuclear cells (PBMCs) and fibroblasts
from a largely aged population with increased risk for
vascular dementia [14]. In this report, decreased telomere
length in both fibroblasts and PBMCs was correlated to
risk for dementia induced by stroke. In addition, telomere
shortening rate was reported to decrease with increasing
antioxidant capacity in fibroblasts of the same population.
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This theory, together with the subsequent data, presents
evidence that, firstly, oxidative stress is responsible for the
accelerated shortening of telomeres brought about by more
frequent reparative replication and, secondly, that an increase
in antioxidant defence capacity could slow down the ageing
process. Note at this point that we do not infer that telomere
shortening results only from oxidative stress: other mech-
anisms such as chromosomal instability have indeed been
linked to both ageing and pathological conditions such as
cancer [15]. However, to remain focused on the main topic
of this review, we have limited this discussion to accelerated
telomere shortening in the context of cumulative oxidative
stress.
Holistic interpretation of the two theories introduced
above implicates oxidative stress as major causative role
player in the damage to cell constituents by oxidising
membranes, molecules, and DNA. This initiates a cascade
of events leading to the need for either cell growth and
replication for repair, or death. This implicates ROS as rate
determining factor of cell lifespan due to the direct damage
it inflicts. Furthermore, oxidative stress is implicated in
causing irreversible damage to the mechanism of replication
through accelerated telomere shortening and thus ultimately
decreases the capacity of the cell to replicate optimally, or at
all. With both repair and replication affected, cell senescence
is encouraged.
In keeping with the idea of a holistic approach, consider-
ation of oxidative stress in isolation is insufficient. A basic but
practical example of the interplay between the oxidative stress
system and another system implicated in ageing, inflamma-
tion [16], is data available on detrimental effects of cigarette
smoking. In this context, both acute smoking and long-term
smoking were shown to overwhelm the glutathione antioxi-
dant defence system within the lungs, which was associated
with significant infiltration of inflammatory immune cells in
the lungs [17]. This study clearly shows system interaction.
Furthermore, in the same study, the severity of this maladap-
tation increased with duration of habitual smoking (in years)
and was exacerbated by natural decreases in antioxidant
capacity as experienced with ageing, resulting in increased
oxidative stress, illustrating the significance of cumulative
damage.
However, before considering these interactions in more
detail, the literature providing proof of a role for chronic
inflammation in the process of ageing will be briefly
reviewed.
3. Chronic Low Grade Inflammation
Facilitates Premature Ageing
As is the case for oxidative stress, the inflammatory response
is a system essential for normal body function [18]. As
component of the innate immune response, inflammation
is a major first-line defence against infection and injury
[18]. Apart from this largely independent, nonspecific role
in immunity, inflammation is also vital for many specific
immune responses to run its course [19]. However, in the
process of repair and restoration after insult, the inflamma-
tory response inadvertently disrupts cellular homeostasis of
previously unharmed or unaffected cells [20, 21]. The injury-
repair cycle which inflammation regulates is an efficient
system during youth, when optimal sensitivity and response
to signalling molecules (such as cytokines, growth factors,
prostaglandins, and peptides) maintain the general health
of circulating immune cells and the tissue microenviron-
ment, with minimum secondary damage. However, during
natural chronological ageing, long-term, repeated stimulus-
response cycles change the receptor expression levels and
thus sensitivity to these molecular stimuli [22]. This may
necessitate relatively increased concentrations of any par-
ticular stimulus to maintain the required effect. Commonly
reported characteristics of the natural ageing process include
inflammation or oxidative stress-associated symptoms such
as directionally inaccurate chemotaxis, premature or sub-
optimal respiratory burst, and increased proinflammatory
signalling from immune cells, all of which form the basis of
immunosenescence [23].
Immunosenescence is the term used to describe ageing of
immune cells and the functioning of the immune system as
a whole. This occurs naturally with advancing chronological
age or as result of lifestyle factors, as already mentioned.
There is more than one way in which the immune system is
compromised upon ageing. Firstly, immunocompetent cells
are derived from hematopoietic stem cells. With ageing, a
natural bias develops for stem cells to commit to expansion of
the myeloid lineage at the cost of the lymphoid lineage [24].
This results in a shift in the balance of immune cells available
to enter the circulation. Secondly, the chronic low grade
inflammation associated with ageing recruits larger num-
bers of cells into circulation from the hematopoietic tissue.
However, despite the higher circulating cell counts, phago-
cyte Toll-like receptor expression and phagocytic capacity
are decreased in the aged [22], leaving the immune sys-
tem with a lower capacity for becoming activated and for
responding to a more acute insult, such as viral infection.
These maladaptations, which together further predispose
the individual to proinflammatory responses, are postu-
lated to stem at least in part from alterations in HPA-axis
signalling.
The process of immunosenescence may be accelerated by
unhealthy lifestyle, such as psychological stress and obesity.
As mentioned before, lifestyle-associated diseases share clin-
ical symptoms associated with normal ageing. Indeed rutin, a
potent antioxidant, has been shown to protect against ageing-
related metabolic dysfunction [25]. Thus, studies focused
on those conditions may provide much insight in terms
of ageing and the supplementation options to limit its
progress.
For example, in the context of obesity and/or inactiv-
ity, cytokines release from adipose tissue macrophages has
been demonstrated by many researchers [26–29]. Tumour
necrosis factor-𝛼 (TNF-𝛼), interleukin- (IL-) 1𝛽, and IL-
6 are among some of the cytokines shown to be released
from resident macrophages in adipose tissue, resulting in
a proinflammatory microenvironment [30]. Furthermore,
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chronic stress, and in particular psychological stress, is a
generally accepted cause of chronic low grade inflammation.
For example, in 38 medical students, psychological stress was
associated with increased proinflammatory cytokine (TNF-
𝛼, IL-6, IL-1Ra, and IFN-𝛾) levels, as well as decreased anti-
inflammatory regulators (IL-10 and IL-4) [31]. Interestingly,
these effects were exacerbated by high anxiety proneness as
trait, again suggesting that a cumulative stimulus (in this
case lifelong anxiety) further exacerbates the undesirable
adaptation.
Also in posttraumatic stress disorder (as extreme form of
chronic psychological stress), an initial glucocorticoid hyper-
response is followed by glucocorticoid hyporesponsiveness,
which is associated by a relatively proinflammatory state. In
this condition of continuous proinflammatory signalling, the
feedback systems, which usually downregulate inflammation,
adjust overtime and result in maladaptations such as chronic
but low grade upregulation of proinflammatory mediators
(e.g., IL-6, TNF-𝛼, IL-1𝛽, and prostaglandin E
2
) [32]. Inciden-
tally, the secretion of the first three is mediated by the NF-
𝜅B pathway, which is activated in response to cellular stress
[33].
In addition to increased proinflammatory signalling,
other more mechanical cellular mechanisms also seem to be
compromised over time. For example, inappropriate and/or
insufficient neutrophil responses result from its decreased
phagocytic capacity, increased basal levels of intracellular cal-
cium, and the resulting reduction in capacity for chemotaxis
[34]. The result is a chronic low grade inflammatory status
in relative absence of a specific threat which can persist for
extended periods of time and cause harm and inefficiency
of the system. Thus, although varied in specific causative
mechanism, the outcome of all of these suboptimal life events
or lifestyle habits, for example, chronic stress leading to
glucocorticoid resistance and/or cardiovascular disease and
high-calorie diets and inactivity (obesity) leading to insulin
resistance and diabetes, is that of a chronic inflammatory state
[16].
Of particular interest in the context of ageing is the fact
that, apart from the nownotorious low grade inflammation as
primary culprit, this maladaptation results in a compromised
capacity to mount an efficient inflammatory response to
acute insults. As overviewed in the review by Weinberger
and colleagues [35], several reports from clinical literature
support the notion that, in the aged individual, that there is
a significant increase in the convalescence period required
for recovery from injury and pathogen clearance, as well as
a decrease in the quality of repair, thus favouring disease
progression andmorbidity due to injury. Very recently, Bae¨hl
and colleagues (2015) demonstrated, in a longitudinal study
of elderly patients, that the acute stress of a hip fracture had
a negative effect on neutrophil function immediately after
injury.While some neutrophil functions (chemotaxis, phago-
cytosis) were recovered over time, several others (superoxide
production, complement C5A and CD11b receptor level,
and cytokine secretory profile) were still impaired even
6 months after injury. From this, the authors concluded
that the acute stress had a long-term negative effect on
neutrophil responses, which negatively influenced clinical
outcomes, such as the resolution of long-term inflamma-
tion, recovery, and susceptibility to opportunistic infections
[36].
It is thus clear that ageing is an inflammatory-mediated
process. However, from the inflammation/ageing literature,
it is clear that inflammation and oxidative stress cannot be
separated as causative factors in this context. For example,
the ageing-related shift in balance between the glucocorticoid
and inflammatory systems has been linked to increased ROS
production, which in turn exacerbates low grade immune
activation [37].
4. Links between Inflammation and
Oxidative Stress in the Ageing Process:
Identifying Therapeutic Targets
From the above sections it is evident that, in ageing, oxidative
stress and inflammation are interdependent mechanisms.
We postulate that unravelling and understanding of these
intricate links between the two responses hold the answer to
identification of the major contributor(s) to allostatic load
and maladaptation associated with ageing and age-related
pathology.
Generally, repeated exposure to reactive oxygen and
nitrogen species causes cell damage and thus a proinflam-
matory signalling response. For example, in aged mice,
unquenched reactive oxygen and nitrogen species act as
proinflammatory signalling molecules and mediators of
inflammation within the cell itself [38]. More specifically,
oxidative damage to cells prompts the release of TNF-𝛼
from these damaged cells [21]. Binding of TNF-𝛼 to cell
surface TNF-𝛼 receptors activates the NF-𝜅B inflammasome,
which results in the further production of other proinflam-
matory cytokines, most notably IL-1𝛽. Incidentally, TNF-
𝛼 specifically has also been implicated in ROS-mediated
upregulation of adhesion molecules which facilitate the
infiltration of immune cells into tissue [39], with more
on this later. Upregulation of inflammation via the NF-𝜅B
inflammasome is probably the main aetiological mechanism
for age-related chronic conditions with an inflammatory
component. Indeed, TNF-𝛼 upregulation, which is a direct
result of increased flux through the inflammasome, has
been implicated as causative factor in cardiovascular disease
[40]. Of particular relevance to the topic of ageing, the
NF-𝜅B inflammasome has regulatory roles in cell growth,
survival, and proliferation. However, as recently reviewed
[41], ROS production may have either inhibitory or stim-
ulatory roles in the NF-𝜅B pathway, suggesting a dose-
dependency of the effects of ROS. This unfortunately also
means that development of an intervention strategy/product
to modulate this target mechanism is no simple feat and
will have to be approached in a very tightly controlled
“modification range.”
From the literature consulted, it is clear that bidirectional
communication is in place. For example, both neutrophils
and macrophages are producers of oxidants via the NADPH-
oxidase system [42]. The NADPH-oxidase (NOX) proteins
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aid the transport of electrons across biological membranes
and are found in all cells [43]. They are also one of the
major generators of ROS in all cells. Particularly, these
proteins are the predominant ROS producers in phago-
cytic cells, a process required for the normal respiratory
burst that phagocytes use to kill pathogens and digest cell
debris.
Furthermore, activated neutrophils release myeloper-
oxidase (MPO), which contributes to the formation of
hypochlorous acid (HOCL) by acting as a catalyst when react-
ing with hydrogen peroxide (H
2
O
2
). This directly increases
the production of ROS [44]. The oxidative burst of neu-
trophils in itself releases oxidants such as H
2
O
2
, which are
harmful to healthy cells and tissue [45]. Besides directly
increasing the production of reactive oxygen species itself
which causes damage to surrounding cells, MPO specifically
has been implicated as a risk factor for coronary artery
disease, due to its capacity for oxidation of lipid mem-
branes [46]. The increased oxidant concentration due to
immune cell functions, as well as the resultant cell damage,
results in increased metabolism in surrounding healthy
tissue.
Also at gene level, role players have been elucidated in the
context of a ROS-inflammation link. For example, sirtuins are
Class III histone deacetylases which are responsible for the
deacetylation at N-epsilon lysine residues, a reaction which
consumes NAD+. SIRT1 specifically is a sirtuin commonly
associated with antioxidant function [47]. Its regulation
of oxidative stress is threefold: firstly, it stimulates the
expression of antioxidants via the fork-head box protein O
(FOXO) pathway. Secondly, it is involved in inhibiting the
NF-𝜅B signalling pathway. In contrast, however, excessive
ROS can inhibit SIRT1 activity by oxidatively modifying
its cysteine residues and thereby releasing its inhibition of
the NF-𝜅B pathway [47]. It is thus theoretically possible
for cumulative stress to downregulate SIRT1 activity in the
ageing process. Thirdly, SIRT1 has also been implicated in
regulation of apoptosis by deacetylating p53 to inhibit p53-
dependent transcription inmodels of cellular stress [48].This
tripartite role defines SIRT1 as another important molec-
ular target in the context of both normal and accelerated
ageing.
Apart from these targets related to cellular signalling,
cell functional capacity should also be a focus. A striking
example of the oxidative stress, inflammation link in age-
ing, is the decreased capacity for neutrophil chemokinesis
reported in the elderly both in terms of motility and accuracy
[49]. Normally, immune cells are attracted by chemotactic
signals from injured tissue, to migrate to sites of injury
or pathogen invasion. During this chemokinetic response,
immune cells, typically neutrophils and classically activated
macrophages, migrate through tissue toward the site of
injury. This movement is facilitated largely via adhesion
molecules such as the beta-integrins and I-CAM1 in the
case of neutrophils [21]. However, as mentioned earlier,
expression of adhesion molecules on neutrophils increases
with ageing [39], so that their movement is slowed. In
addition, due to yet unclear mechanisms, but most probably
due to adaptation of cellular “homing” molecules, directional
accuracy of neutrophil migration is also compromised in
the elderly. Sapey et al. showed that inaccurate neutrophil
migration was causally associated with increased constitu-
tive phosphoinositide 3-kinase (PI3K) signalling [49]. This
results not only in inefficient inflammation due to prolonged
response time, but the directional inaccuracy of movement
also results in mechanical and oxidative damage to relatively
more cells in the path of the migrating inflammatory cell
[49].
It is clear that both oxidative stress and inflammation
are able to induce and exacerbate one another (both indi-
rectly and directly). Furthermore, regardless of the primary
signal or which pathway was activated first, these inter-
related processes form a vicious cycle which is difficult
to target therapeutically because of its complexity. How-
ever, it is also this interrelated nature of the two systems
that has led us to investigate the possibilities of antiox-
idants as treatment options to attenuate the cumulative
effects of oxidative stress and in turn low grade chronic
inflammation.
5. Are Grapes the Answer to
Prevention of Ageing?
Despite the huge range of nonsteroidal and natural product
anti-inflammatories on the market today, the scientific litera-
ture shows a conspicuous lack of consistent support for any
specific medication. This is perhaps at least in part due to
the fact that researches investigating these products cannot
keep up with the rate at which new ones are pushed onto
the market. Hopefully new legislation on the control of these
substanceswill affect this trend to the benefit of the consumer,
by allowing for (or demanding) appropriate testing of these
products.
Nevertheless, antioxidants are being used almost rou-
tinely by many individuals who wish to supplement for
enhancement of general health or as adjuvant therapy in con-
junction withmoremainstream, pharmaceutical medication.
Although they are generally not regarded as a primary ther-
apeutic option, antioxidants may hold particular potential in
the realm of preventative medicine. The potential benefits of
appropriate antioxidant supplementation are vast, especially
when considering the connection between oxidative stress
and inflammation. An antioxidant with the capacity to
modulate inflammatory status can thus be beneficial to both
normal ageing individuals and those suffering from lifestyle-
associated diseases.
A comprehensive search of the scientific literature
revealed that grape-derived antioxidants are consistently
reported to have high benefit and low risk in the context
of both oxidative stress and inflammation. These positive
results are further strengthened by the fact that these con-
sistent findings were reported across many different mod-
els and using a variety of different preparations, ranging
from relatively crude extracts to highly purified ones. For
example, in terms of purified polyphenols, resveratrol, one
of the best-known polyphenols present in grapes as well as
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other plants, is commonly linked to anti-inflammatory [50],
antioxidant [51, 52], and thus by implication antiageing effects
in the scientific literature, as well as anecdotally. Indeed, a
recent paper [53] elucidated a role for resveratrol to protect
against inflammatory damage via SIRT1 inhibition of the NF-
𝜅B pathway (a mechanism discussed above in the context
of ageing). In addition, more advanced studies have been
undertaken on this polyphenol to better understand the rela-
tionship between the chemical structure of resveratrol and its
biological activity, especially in terms of oxidant scavenging
[54]. Also, pharmaceutical groups have been working on
optimisation of delivery systems for resveratrol [55]. Such
information may further advance the popularity of this very
promising natural product with the pharmaceutical industry,
to the benefit of consumers. The phenomenal frequency
at which new papers on resveratrol appear, all providing
evidence of positive effects in this context, suggests that this
particular polyphenol should be investigated in the context of
ageing as a matter of urgency.
Even more promising than the many positive effects
described for resveratrol above is the fact that resveratrol
is only one from a range of equally beneficial substances
contained in grapes. The flavonoids quercetin and dihydro-
quercetin (DHQ), as well as proanthocyanidins and antho-
cyanins, all of which are present in grapes and a variety
of other plant sources, have similarly been linked to both
antioxidant and anti-inflammatory effects [50, 52]. To date,
despite appearance of a few very promising reports in this
context, ageing specifically has not been the focus of many
studies investigating these substances. Therefore, for the
purpose of this review, we provide a comprehensive overview
of the few existing ageing-related studies in this context that
were available to us. Results from relevant papers that did
not have ageing as a focus were also included, where those
results contribute to our understanding of the role of grape-
derived polyphenols in the oxidative stress, inflammation link
in the context of prevention or deceleration of the ageing
process.
When considering in vivo studies on ageing as a starting
point, resveratrol (0.1 𝜇M to 2.5 𝜇M) exhibited a clear dose-
dependent effect on longevity in fish with known short
lifespan: resveratrol supplemented fish almost doubled their
expected 13-week lifespan and continued to produce healthy
offspring long after all control fish had died. Even though
resveratrol supplementation was only started in adulthood
in this study (i.e., it compares to when humans might
start to consider supplementation), it effectively delayed age-
dependent compromise of locomotor and cognitive per-
formance and reduced expression of neurofibrillary degen-
eration in the brain [56]. This result of improved neural
morphology was recently further substantiated in an aged
rat model, where chronic resveratrol treatment prevented
detrimental changes in dendriticmorphology which is linked
not only to ageing, but also to Alzheimer’s disease [57].
Similarly, 2 months of ingesting polyphenols in the form
of 10% grape juice resulted in enhanced potassium-evoked
dopamine release and cognitive performance in aged rats
[58].
A more recent review [59] provides more insight into
the potential mechanisms by which age-related cognitive
disorders may be curbed by grape polyphenols. Some of
these mechanisms at first seem unrelated to the scope of this
review, for example, preventing of amyloid-beta deposition
associated with Alzheimer’s dementia [60]. However, recent
research suggests a role for inflammation in the develop-
ment of the disease [61], while natural antioxidants have
been linked to prevention of amyloid-beta deposition [62].
Together, these data suggest that even these seemingly unre-
lated mechanisms may be interconnected to either inflam-
mation, or oxidative stress, or both. However, more clearly
in context of this review, resveratrol was reported to increase
NO production, resulting in vasodilation [59, 63], whichmay
play a role in the maintenance of central circulation and
thus perhaps slower degenerative central processes, as has
indeed been reported for resveratrol, as mentioned earlier.
However, the role of NO in the context of antioxidant
status is much more complex, so that this effect of grape
polyphenols should probably receive more attention before
it can be interpreted fully in terms of mechanism(s) involved.
Furthermore, recently in a coculture simulation of the human
blood-brain barrier, another grape polyphenol, proantho-
cyanidin, was associated with significant inhibition of mono-
cyte infiltration and proinflammatory cytokine secretion in
HIV-associated neuroinflammation [64]. Such inhibition of
neuroinflammation is associated with a better prognosis
in terms of HIV-related neurodegeneration and dementia,
further confirming the neuroprotective potential of grape-
derived antioxidants. Taken together, these studies suggest
that the neuroprotective effects of grape polyphenols involve
both antioxidant and anti-inflammatory mechanisms, with
the latter including not only modulated cytokine signalling,
but also modulation of both motility and functional capac-
ity of leukocytes, as previously illustrated by our group
[64, 65].
One may argue that both these results may be the result
of decreased cell activation, perhaps as a result of the known
altered cytokine environment. However, an age-associated
lack of neutrophil chemokinetic accuracy in response to the
chemotaxin fMLP has been reported [49], which suggests
that the mechanism is probably related to age-induced
compromise of specific cellular mechanisms, rather than
activation. In addition, in an ongoing study by our group, we
have been able to illustrate by using Dunn chamber chemoki-
netic assays that grape polyphenols (specifically proantho-
cyanidin) are able to correct this age-associated anomaly
(unpublished data). From Figure 1, which depicts typical
digital images obtained for the path of individual neutrophils,
it is clear that amore purposeful, directionally accuratemove-
ment was achieved in proanthocyanidin-treated neutrophils.
This will ensure a more optimal inflammatory response (i.e.,
the response will be effective, result in relatively insignificant
secondary damage, and be resolved in the minimum amount
of time). In contrast the rather “aimless wander” of untreated
neutrophils from aged individuals will result in not only
ineffective immune cell infiltration to sites where they are
required, but also relatively more secondary tissue damage
and thus prolonged and exacerbated inflammation.
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Figure 1: Typical neutrophil chemotaxis pathways for (a) a young participant (<25 yr), (b) an aged participant (>65 yr), and (c) an aged
participant after acute in vitro treatment with grape-deed derived proanthocyanidin. The Olympus Cell system IX-81 inverted fluorescent
microscope system with an F-view cooled CCD camera (Soft Imaging Systems) at 20x magnification was used to capture these images, which
was analysed using Image J (Java software).
Turning attention to inflammation and oxidative stress
again, the most probable targets for therapeutic intervention
in the context of ageing have been described in Section 4.
Since the ageing literature is relatively lacking in terms of
papers on polyphenol intervention, we have tabulated effects
of grape polyphenols reported for these identified targets
in Table 1, citing relevant data that was mostly obtained in
models other than ageing. The aim with this table was not
to present all studies on grape-derived products; rather, it is
an attempt to show the many models, species, and disease
systems in which beneficial effects on oxidative stress and
inflammatory status have consistently been reported. Also,
although we have included doses used for in vivo studies for
general comparison and again to illustrate the large variations
in doses, these doses are product/extract specific and cannot
be extrapolated across board.
From Table 1, which is by no means a complete list of
all studies reporting on grape-derived substances, grape-
derived products are undeniably beneficial in limiting the
magnitude of the inflammatory response as well as to
increase antioxidant activity and seem to have multiple
targets.
Of course, when considering potential antiageing modal-
ities, it is also of interest to include evaluation of changes
in quality of life. Since ageing is associated with natural
muscle wasting or sarcopenia [83], it is important to note
that, in this context, supplementation with grape polyphe-
nols (50mg/kg/day) for 4 weeks mitigated skeletal muscle
atrophy in a mouse model of chronic inflammation [84].
This was achieved via modulation of two distinct pathways:
one directly linked to inflammation (decreased NF-𝜅B acti-
vation) and the other due to antioxidant function (limited
ROS-associated mitochondrial damage and caspase-3 and
-9 activation). Since caspase-3 activation is also a known
proapoptotic signal [85], reduced activation and thus apop-
tosis may result in fewer mitotic cycles.This, in the context of
the telomere hypothesis, may point to deceleration of ageing
by the polyphenols. Very recently, grape proanthocyanidin
treatment in rats was reported to have an antiapoptotic effect
which reduced damage after ischemia/reperfusion of the liver
[86], which further substantiates this theory.
Interestingly, a study in mice fed a high-fat diet indicated
that grape polyphenolsmaymodify gutmicrobial community
structure to result in lower intestinal and systemic inflamma-
tion [87].This extraordinary result serves to remind us of the
potential complexity of plant medicines and the requirement
for comprehensive investigation of mechanisms of actions
and interactions of any potential product via the traditional
clinical trial process followed for new pharmaceutical drugs.
6. Conclusion
Ageing and accelerated ageing are not new concepts, but
rather the norm in modern society. With a population that
is growing relatively older due to advances in medicine,
we are however pressed for answers on how to alleviate
the symptoms or slow the progression of this inevitable
phenomenon. From the literature consulted, no negative
effects of grape-derived products became evident, while
beneficial effects in the context of oxidative stress and
inflammation were consistently reported in the context of
numerous cellular targets. Huge variation in product content
and prescribed dosage complicates interpretation of the fast
growing body of literature on this topic. A recommendation
for future studies is the inclusion of more parameters per
study, so that amore comprehensive interpretation of specific
mechanisms becomes possible. Measurement of only basic
indicators of either antioxidant status or inflammatory status,
while providing proof of efficacy of the product, does not
contribute much information on its mechanism of action.
Despite this shortcoming, the literature clearly indicates that
grape-derived products are undeniably a therapeutic force
to be reckoned in the combat of ageing and age-associated
conditions.
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